Delivery Order SPE2DB20D1100-SPE2DB25FB8P4
- Not listed
- The Defense Logistics Agency awarded a $4,211.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 1, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,995.78 on May 20, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL quantities. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of May 21, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with DLA, one of the Department of...
- AmerisourceBergen Drug Corp was awarded a $4,896.10 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 29, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL unit doses, with a ceiling value of $1,599.58. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,020.74 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $5,405.03 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Imitrex 4 mg/0.5 mL pen injections (0.5 mL units). The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,501.15 and completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,595.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Imitrex 4 mg/0.5 mL pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency has awarded a $2,288.07 delivery order to AmerisourceBergen Drug Corp for IMITREX 4 mg/0.5 mL pen injectors, with an ultimate completion date of May 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and the company's corporate office is designated as both the...
- The Department of Defense awarded a delivery order valued at $2,278.68 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL formulations. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is funded through the Defense Logistics...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB8P4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,289.80 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml pen injectors on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order executed under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, where the organization maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to military healthcare systems and enables the company to supply a wide range of medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's competitive positioning within the DLA's pharmaceutical supply chain reflects its capability to fulfill federal medical requirements, and the company continues to serve critical customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 4/21/25 |